COAL INDIA LIMITED Tender by Northern Coalfields Limited (GEM/2025/B/6110750)

1 MOXIFLOXACIN 0 POINT 3 PERCENT EYE DROPS 5 ML VIAL,2 MOXIFLOXACIN 0 POINT 5 PERCENT W AND W 5 GM

Goods
Qty:24.1K
EMD: ₹9,854
EST Bid: ₹17.1 Lakh
COAL INDIA LIMITED Tender by Northern Coalfields Limited (GEM/2025/B/6110750)

Tender Timeline

Tender Issue
May 1, 2025 at 1:34 PM

Tender Title: Supply of Ophthalmology Group of Miscellaneous Medicines
Tender Reference Number: GEM/2025/B/6110750
Issuing Authority: COAL INDIA LIMITED
Department: Ministry of Coal

The Supply of Ophthalmology Group of Miscellaneous Medicines tender is issued by the COAL INDIA LIMITED under the Ministry of Coal with the objective of procuring specific ophthalmological medications, particularly Moxifloxacin eye drops and ointments, to meet the medicinal needs of healthcare facilities associated with the Ministry. This initiative aims to ensure consistent availability of high-quality medicines for effective eye care treatments.

Scope of Work and Objectives

The scope of this tender encompasses the supply of various Moxifloxacin formulations:

  • Moxifloxacin 0.3% eye drops in 5 ml vials
  • Moxifloxacin 0.5% ointment in 5 gm tubes

The total quantity required for this tender is 24,050 units, distributed among the specified formulations. Vendors are expected to provide timely delivery to designated medical centers, ensuring that all supplied products meet regulatory standards and specifications for ophthalmologist use.

Eligibility Criteria

Vendors interested in this tender must meet the following eligibility criteria:

  • Must be a registered entity in India and compliant with local healthcare regulations.
  • Should possess all necessary licenses for pharmaceutical distribution and supply.
  • Must demonstrate the capability to deliver the entire quantity outlined in the tender within the stipulated timeframe.

Technical Requirements

All products supplied under this tender must comply with established technical specifications, including:

  • Quality Assurance Standards: All medicines must be manufactured in facilities accredited by regulatory bodies.
  • Type Approval: Vendors must provide proof of compliance with national regulations concerning pharmaceutical products.
  • Documentation: Submission of detailed product information and analysis reports for each product offered will be mandatory.

Financial Requirements

To participate in this tender, bidders must fulfill specific financial requirements:

  • Submission of an Earnest Money Deposit (EMD) as specified in the tender documentation.
  • Demonstration of financial viability and stability through available financial statements and records.

Document Submission Details

Interested vendors must ensure that all required documents are prepared in compliance with the submission format outlined in the tender:

  • All documents must be submitted in PDF format unless specified otherwise.
  • A complete list of required documentation must include registration certificates, quality compliance reports, and other relevant credentials detailed in the tender.

Special Provisions

For Micro, Small and Medium Enterprises (MSEs), there may be special provisions and benefits applicable in the evaluation process, allowing for enhanced consideration during the bidding stage. Startups may also take advantage of provisions designed to encourage participation from emerging businesses, in line with the government's commitment to fostering innovation and local procurement.

Evaluation Process

The evaluation process for bids will be based on predetermined criteria which will consider technical compliance and price competitiveness. Bids will undergo a rigorous assessment to identify the best proposal that meets the designated quality and financial stipulations. Notifications regarding the results will be communicated to all participants following the evaluation.

Delivery Locations

The delivery locations for this tender will be specified in the subsequent procurement communication. Vendors are responsible for ensuring that all products are delivered to the designated medical facilities in compliance with any logistical requirements imposed by the evaluating authorities.

Contact Information

For further inquiries or clarifications, interested parties may refer to the official contact details provided in the tender documentation.

Tender BOQ Items

14 Items
1.

1 MOXIFLOXACIN 0 POINT 3 PERCENT EYE DROPS 5 ML VIAL

MOXIFLOXACIN 0 POINT 3 PERCENT EYE DROPS 5 ML VIAL

Qty:7000
Unit:vial
60
2.

2 MOXIFLOXACIN 0 POINT 5 PERCENT W AND W 5 GM TUBE

MOXIFLOXACIN 0 POINT 5 PERCENT W AND W 5 GM TUBE

Qty:300
Unit:tube
60
3.

3 CIPROFLOXACIN 0 POINT 3 PERCENT EYE DROPS

CIPROFLOXACIN 0 POINT 3 PERCENT EYE DROPS

Qty:300
Unit:vial
60
4.

4 CIPROFLOXACIN 0 POINT 3 PERCENT PLUS DEXAMETHASONE 0 POINT 1 PERCENT EYE DROPS

CIPROFLOXACIN 0 POINT 3 PERCENT PLUS DEXAMETHASONE 0 POINT 1 PERCENT EYE DROPS

Qty:200
Unit:vial
60
5.

5 TOBRAMYCIN 0 POINT 3 PERCENT EYE DROPS 5 ML VIAL

TOBRAMYCIN 0 POINT 3 PERCENT EYE DROPS 5 ML VIAL

Qty:1000
Unit:vial
60
6.

6 TIMOLOL MALEATE 0 POINT 5 PERCENT EYE DROPS 5 ML VIAL

TIMOLOL MALEATE 0 POINT 5 PERCENT EYE DROPS 5 ML VIAL

Qty:1000
Unit:vial
60
7.

7 PHENYLPHRINE HCL 5 PERCENT PLUS TROPICAMIDE 0 POINT 8 PERCENT EYE DROPS

PHENYLPHRINE HCL 5 PERCENT PLUS TROPICAMIDE 0 POINT 8 PERCENT EYE DROPS

Qty:1000
Unit:vial
60
8.

8 CARBOXY METHYL CELLULOSE 0 POINT 5 PERCENT LUBRICANT EYE DROPS

CARBOXY METHYL CELLULOSE 0 POINT 5 PERCENT LUBRICANT EYE DROPS

Qty:10000
Unit:vial
60
9.

9 HYDROXYPROPYL METHYLE CELLULOSE 2 PERCENT W AND V INJECTION

HYDROXYPROPYL METHYLE CELLULOSE 2 PERCENT W AND V INJECTION

Qty:500
Unit:vial
60
10.

10 OLOPATADINE HCL 0 POINT 1 PERCENT EYE DROPS

OLOPATADINE HCL 0 POINT 1 PERCENT EYE DROPS

Qty:1200
Unit:vial
60
11.

11 NEPAFENAC 0 POINT 1 PERCENT W AND V EYE DROPS 5ML VIAL

NEPAFENAC 0 POINT 1 PERCENT W AND V EYE DROPS 5ML VIAL

Qty:500
Unit:vial
60
12.

12 PHENYLEPHRINE PLUS NAPHAZO EYE DROPS 10ML VIAL

PHENYLEPHRINE PLUS NAPHAZO EYE DROPS 10ML VIAL

Qty:500
Unit:vial
60
13.

13 TRYPAN BLUE 0 POINT 8 MG PER ML AMP 5 ML AMP

TRYPAN BLUE 0 POINT 8 MG PER ML AMP 5 ML AMP

Qty:500
Unit:amp
60
14.

14 RANIBIZUMAB 10MG PER ML INJECTION

RANIBIZUMAB 10MG PER ML INJECTION

Qty:50
Unit:pfs
60

General Information

Item Category
1 MOXIFLOXACIN 0 POINT 3 PERCENT EYE DROPS 5 ML VIAL , 2 MOXIFLOXACIN 0 POINT 5 PERCENT W AND W 5 GM TUBE , 3 CIPROFLOXACIN 0 POINT 3 PERCENT EYE DROPS , 4 CIPROFLOXACIN 0 POINT 3 PERCENT PLUS DEXAMETHASONE 0 POINT 1 PERCENT EYE DROPS , 5 TOBRAMYCIN 0 POINT 3 PERCENT EYE DROPS 5 ML VIAL , 6 TIMOLOL MALEATE 0 POINT 5 PERCENT EYE DROPS 5 ML VIAL , 7 PHENYLPHRINE HCL 5 PERCENT PLUS TROPICAMIDE 0 POINT 8 PERCENT EYE DROPS , 8 CARBOXY METHYL CELLULOSE 0 POINT 5 PERCENT LUBRICANT EYE DROPS , 9 HYDROXYPROPYL METHYLE CELLULOSE 2 PERCENT W AND V INJECTION , 10 OLOPATADINE HCL 0 POINT 1 PERCENT EYE DROPS , 11 NEPAFENAC 0 POINT 1 PERCENT W AND V EYE DROPS 5ML VIAL , 12 PHENYLEPHRINE PLUS NAPHAZO EYE DROPS 10ML VIAL , 13 TRYPAN BLUE 0 POINT 8 MG PER ML AMP 5 ML AMP , 14 RANIBIZUMAB 10MG PER ML INJECTION
Ministry Name
Ministry of Coal
Department Name
COAL INDIA LIMITED
Organisation Name
Northern Coalfields Limited

Financial Information

Estimated Bid Value
₹17,09,265.60
EMD Amount
₹9,854.00
Bid Offer Validity
120 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
Inspection Required
Yes
Technical Clarifications Time
5 Days

Tender Documents

5 Documents
GeM-Bidding-7707260.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
Buyer uploaded ATC documentATC ATC
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • OEM Authorization Certificate *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Human Insulin Analogue Rapid acting Inj 100 IU per ml 300 IU Disposable Pen with 5 needles per pen,

GEM
Goods
Qty:2,025
4 Files
Indian Army
PUNE, MAHARASHTRA
Boq › Boql
Human Insulin Analogue Rapid acting Inj 100 IU per ml 300 IU Disposable Pen with 5 needles per pen , Tab Brivaracetam 100 mg , Virgin Linseed Oil 3 percent Diclofenac Diethylamine 1 point 16 percent Methyl Salicylate 10 percent and Menthol 5 percent Topical Spray 35g per 50ml , Rosuvastatin 20 mg Tab , Prochlorperazine Maleate 5 mg Tab , Sulphasalazine 500 mg Tab
May 3, 2025
May 24, 2025 at 1:00 PM
View Details

Sevoflurane Bottle of 250 ml,Isoflurane Bottle of 100 ml,Inj Diclofenac 25 mg ml IP 3 ml,Inj Fosphe

GEM
Goods
Qty:4,036
4 Files
Indian Army
JAMMU, JAMMU & KASHMIR
Boq › Boql
Sevoflurane Bottle of 250 ml , Isoflurane Bottle of 100 ml , Inj Diclofenac 25 mg ml IP 3 ml , Inj Fosphenytoin 75 mgml 2ml ampoule , Morphine 15 mg 1 ml Inj , Inj Diltiazem 5mgml , Inj Promethazine HCl 2 point 5 , Inj Dopamine HCl 40 mg ml 5ml , Inj Prochlorperazine 12 point 5mg ml , Ketamine HCl 50 mg ml 2 ml Inj , Propofol 1 or 10mg ml 20 ml Inj , Bupivacaine HCl 5 mg ml 20 ml Inj , Bupivacaine HCl 5 mg ml heavy 4 ml Inj , Lignocaine HCl without Adrenaline 30 ml Inj , Midazolam 5 mg 1 ml Inj , Inj Pentazocine Lactate 30 mg ml 1 ml Amp , Fentanyl Citrate 50 mcg ml 2 ml Inj , Fentanyl 50 mcg ml Inj , Carboprost Tromethamine 250 mcg per 1ml Inj , Atracurium 10 mgml 2 point 5 ml Inj , Glycopyrrolate 0 2 mgml 1ml Inj , Neostigmine 0 point mg 1 ml Inj , Succinylchloline Chloride 50 mg ml 2 ml Inj , Vecuronium Bromide 4mg ml 1 ml Inj , Haloperidol 5mg per ml Inj , Dextrose 50 percent 25 ml Inj , Dextrose Inj 25 persent 25 ml Inj , Potassium Chloride 15 Inj amp of 10 ml , Atropine Sulphate 0 point 6 mg 1 ml Inj , Lignocaine HCl solution 2 persent for IV use Vial of 50 ml , Noradrenaline Bitartrate 2 mg ml 2 ml Inj , Adrenaline Tartrate 1 is two 1000 1 ml Inj
May 3, 2025
May 24, 2025 at 1:00 PM
View Details

Nintedanib 100 mg Soft gelatin cap,Tab Acarbose 25 mg,Tab Telmisartan 20 mg,Carvedilol 6 point 25 m

₹1,450.00
GEM
Goods
Qty:14.1L
5 Files
Indian Army
KOLKATA, WEST BENGAL
Boq › Boql
Nintedanib 100 mg Soft gelatin cap , Tab Acarbose 25 mg , Tab Telmisartan 20 mg , Carvedilol 6 point 25 mg Tab , Tab TRANEXAMIC ACID 250 mg , Tab Chlorthalidone 12 point 5 mg , Cilastazole 50 mg Tab , Tab Cilostazole 100 mg , Tab Danazol 100 mg , Anastrozole 1mg Tab , Cyclosporine A micro emulsion 25 mg Cap , Tab Leflunomide 10 mg , Tab Cinnarizine 25 mg , Tab Betahistine 16 mg , Fluvoxamine 50 mg Cap , Isoniazid 300 mg Tab , Gycerl Trinitrate CR 2 point 6 mg, Tab , TAB PIRACETAM 800 MG , Quitiapine 50 mg, Tab , Risperidone 4 mg Tab , Bethanechol 25mg Tab , Tab Tadalafil 10 mg , Mebeverine HCl 135mg Tab , Common Cold Tab Cetrizine 5 mg plus Paracetamol 500 mg plus Pseudoephdrine 60 mg , Tab Fenofibrate 160 mg , Moxifloxacin Hcl 0 point5 percent plus Dexamethasone 0 point 1 percent ophthalmic soln bott of 5 ml , E slace D Brinzolamide 1 percent , Brimonidine 0 point 2 percent plus Timolal eye drops, bott of 5 ml , Formeterol 20 mcg plus budesonide 0 point 5 mg respules , Human Insulin Analogue Glargine Inj, 100 IU slace ml Recombinant DNA origin 300IU Disposable Pen with 5 needles per pen , Tab Bisoprolol 5mg , Chloridiazepoxide 10 mg Tab , Tab Cilnidipine 5 mg , Glipizide 5 mg Tab , Clobazam 5 mg Tab , Fludrocortisone 0 point 1mg Tab , Tab Mirabegron 50 mg , Tab Voglibose 0 point 3 mg , Tab Rosuvastatin 10 mg , TAB ZIPRASIDONE 20 MG , Tab Midodrine 2 point 5mg , Tab Dutasteride 0 point 5 mg , Tab Clotrimazole 100 mg Vaginal Pessary , Tab Donepezil 10mg , Tab Methotrexate 15 mg , Tab Melatonin 3 mg , Fluconazole 0 point3 percent wslace v bott of 5 ml , Rizatriptan 5 mg Tab , Timolol Maleate 0 point 5 percent Preservative Free with Comod System , Tab Primidone 250 MG , Chloramphenicol 5 percent w slace v Clotrimazole 1 percent w slace v Betamethasone 0 point 25 percent wslace v Lignocaine HCL 2percent w slace v in bott of 5 ml , Cough Lozenges , Fluoxetine HCl 20 mg Cap , Tamsulosin 0 point 4mg and Dutasteride 0 point 5mg combination Cap slaceTab , Amlodipine 10 mg Tab , Alprazolam 0 point 5 Mg Tab , Dimethyl Fumarate 240 mg delayed release Capsules containing microteblets , Isosorbide Mononitrate 20 mg Tab , Tab Levetiracetam 250mg
May 3, 2025
May 24, 2025 at 1:00 PM
View Details

SYP CREMAFFIN WHITE EACH 15 ML CONTAINING MILK OF MAGNESIA 11 point 25 ML LIQ PARAFFIN 3 point 75 M

GEM
Goods
Qty:10.8L
4 Files
Indian Army
HYDERABAD, TELANGANA
Boq › Boql
SYP CREMAFFIN WHITE EACH 15 ML CONTAINING MILK OF MAGNESIA 11 point 25 ML LIQ PARAFFIN 3 point 75 ML BOTT OF 170 ML , CAP TAMSULOSIN HCL 0 point 4 MG , TAB RANOLAZINE 500 MG , TAB TICAGRELOR 90MG , TAB SITAGLIPTIN PHOSPHATE 50 MG , TAB SITAGLIPTIN 50 MG METFORMIN 1000 MG , TAB RABEPRAZOLE 20 MG , TAB URSODEOXYCHOLIC ACID 300MG , CAP CALCIUM CARBONATE 500 MG CALCITRIOL 0 point 25 MCG VIT K2 7 50 MCG ZINC 7 point 5 MG MAGNESIUM 50 MG , Bilastine 20mg Montelukast 10mg Tab , INJ HUMAN INSULIN LISPRO 50 per 50 100IU per ML , INSULIN ACTRAPID 30 per 70 , DIABETIC PROTEIN POWDER , INHALER SALMETEROL 25 MCG FLUTICASONE PROPIONATE 250 MCG , TAB ESOMEPRAZOLE 40 MG , Tab Orofer XT , TAB CANAGLIFLOZIN 100MG , TAB ROSUVASTATIN 20 MG , TAB ESOMEPRAZOLE40 MG LEVOSULPRIDE 75MG , TAB ATORVASTATIN 40 MG , TAB GABAPENTIN 300 MG METHYLCOBALAMINE 0 point 5 MG ALPHA LIPOLICACID 100 MG , TAB RASAGILINE 1 MG , TAB CEFPODOXIME 200 MG CLAVULANIC ACID 125 MG , TAB VALSARTAN 160 MG , TAB GABAPENTIN 400 MG NORTRYPTILLIN 10 MG , CAP ALPHALIPOLIC ACID VIT D3 VIT B COMPLEX , CAP CALCIUM CARBONATE SOFT GEL , TAB CHONDROITIN SULPHATE 200 MG COLLAGEN PEPTIDE40 MG SODIUM HYALURONATE 30 MG VIT C 35 MG , TAB COMMON COLD ANTIHISTAMINICS PARACETAMOL 500 MG WITHOUT PSEUDO EPHEDRINE , TAB NEPHROCAPS , TAB ETODOLAC 600 MG , TAB EVOGLIPTIN 5 MG , Tab Olmesartan 40mg Chlorthalidone 12 point 5mg
May 3, 2025
May 24, 2025 at 12:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity, compliant with pharmaceutical regulations in India, and possessing the necessary licenses for distribution of medicinal products. Vendors must demonstrate their operational capabilities to fulfill the tender’s requirements, particularly regarding the supply of Moxifloxacin medications and must maintain quality assurance procedures.

Vendors must provide relevant certificates that include product registration certificates, quality compliance documents that prove adherence to national standards, and any licenses necessary for the manufacture and distribution of the pharmaceutical products being tendered.

Vendors must prepare and submit their bids electronically in PDF format. All necessary documentation including technical specifications, financial statements, and compliance certificates must be included as per the guidelines outlined in the tender documentation to ensure a complete submission.

Payment terms will typically be outlined in the final award notification. Generally, successful bidders may receive an advance upon delivery and acceptance of goods, and final payments may be processed post-receipt of all required compliance checks and quality assurance verifications.

Yes, there are provisions in place for Micro, Small, and Medium Enterprises (MSEs) that may facilitate a smoother evaluation process. Startups are also encouraged to apply, benefitting from specific advantages designed to promote participation from new and innovative companies within the pharmaceutical sector.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders